C4 Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CCCC and other ETFs, options, and stocks.

About CCCC

C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system. 

CEO
Andrew J. Hirsch
CEOAndrew J. Hirsch
Employees
145
Employees145
Headquarters
Watertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded
2015
Founded2015
Employees
145
Employees145

CCCC Key Statistics

Market cap
423.27M
Market cap423.27M
Price-Earnings ratio
-2.31
Price-Earnings ratio-2.31
Dividend yield
—
Dividend yield—
Average volume
1.24M
Average volume1.24M
High today
$6.37
High today$6.37
Low today
$6.12
Low today$6.12
Open price
$6.30
Open price$6.30
Volume
1.05M
Volume1.05M
52 Week high
$11.88
52 Week high$11.88
52 Week low
$1.06
52 Week low$1.06

Analyst ratings

67%

of 9 ratings
Buy
66.7%
Hold
33.3%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.